Synopsis: Posting its strongest annual earnings in recent years, Apcotex Industries reported an 87.6 percent jump in full-year net profit for FY26, while the board simultaneously approved a renewable energy stake acquisition to secure captive solar power, a move that aligns energy cost management with the company’s long-term operating strategy.
A specialty chemicals company known for its synthetic rubber and latex portfolio delivered a sharp earnings recovery in FY26, drawing attention from investors tracking the mid-cap chemicals space. The results landed alongside a board-approved solar energy play, a strategic move that sets up the company’s energy infrastructure for the years ahead and adds an ESG dimension to an already compelling earnings story.
With a market capitalization of Rs. 2,651 crore, the shares of Apcotex Industries were trading at Rs. 511 per share; the stock hit the upper circuit of 20 percent on May 7, 2026. The stock carries a P/E ratio of 26x.
Q4 and Full Year Financial Performance
The numbers for FY26 tell a straightforward recovery story. Full-year revenue from operations came in at Rs. 1,442 crore, up from Rs. 1,392 crore in FY25, a modest topline expansion of roughly 3.5 percent. Where the real movement showed up was at the bottom line. Net profit for the full year landed at Rs. 101 crores, up 87.6 percent from Rs. 54 crores in FY25. Earnings per share for FY26 stood at Rs. 19.56, nearly double the Rs. 10.43 recorded the previous year.
Q4 alone saw a net profit of Rs. 35 crore, a 106 percent jump over the sequential quarter’s Rs. 17 crore figure driven partly by lower material costs and working capital improvements. Operating cash flow for the year surged to Rs. 203.43 crores, compared to Rs. 84.72 crores in FY25, giving management considerably more room to pursue capital allocation decisions. The board recommended a final dividend of Rs. 5.50 per share, face value of Rs. 2.00, which is 275% of face value.
Total debt fell meaningfully over the year. Non-current borrowings dropped from Rs. 62.35 crore to Rs. 31.65 crore, while current borrowings also contracted, a trend the company attributed to strong operating cash generation rather than equity dilution.
The Green Energy Pivot
The sharper strategic story from the May 6 board meeting was the renewable energy decision. Apcotex had earlier, in March 2026, intimated to exchanges that it intended to source captive solar power through Amplus Ceres Solar Private Limited. That arrangement ran into a wall: power was simply unavailable through that entity. Rather than sit on the decision, management moved quickly and approved a switch to Amplus Ampere Private Limited, a special purpose vehicle under Amplus Energy Solutions PTE Limited.
Under the revised structure, Apcotex will acquire a 1.275 percent stake in Amplus Ampere for Rs. 72 crore in cash. The objective is captive consumption of solar power that Amplus Ampere will generate. At Rs. 72 crores, the financial outlay is minimal relative to the company’s balance sheet, but the strategic intent is clear. For a manufacturer that consumes significant energy in polymer and rubber production, locking in a captive renewable supply is a direct cost management move. The board authorized officials to execute revised PPAs, share acquisition agreements, and all associated documentation, removing procedural delays from the equation.
Verdict
Apcotex’s FY26 story is a clean earnings recovery amplified by margin expansion rather than topline growth, the kind of quality-of-earnings improvement that mid-cap chemical investors find credible. The solar stake reframes a routine energy procurement decision as a cost-structure play, which adds strategic texture without overpromising. Retail investors tracking the specialty chemicals space will find both the profit rebound and the capital allocation signals worth noting.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
